Arbutus Biopharma Corp
Arbutus Biopharma Corp (NASDAQ: ABUS) is trading at $4.85, about ₹465 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 0.61% today. Indian residents can buy Arbutus Biopharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$4.84
Today's high
$4.93
52 week low
$3.50
52 week high
$5.45
ABUS opened at $4.89, closed previously at $4.88, and has traded between $3.50 and $5.45 over the past 52 weeks.
About
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients’ HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Key statistics
Avg. volume
3.23M
Market cap
$958.06M
P/E Ratio
6.14
Price-to-sales ratio
5.27
Enterprise value
$942.51M
Free cash flow yield
-2.57%
Debt-to-equity ratio
0.01
Return on equity
90.98%
ROIC
54.29%
Beta
0.62
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$14.08M
Earnings per share
-$0.17
Free cash flow
-$39.64M
Net profit margin
84.23%
Gross margin
99.98%
EBITDA
-$33.04M
Revenue growth
128.21%
Similar securities
This is not an investment recommendation
How to buy Arbutus Biopharma from India
Indian residents can buy Arbutus Biopharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Arbutus Biopharma and place an order
Find Arbutus Biopharma by name or by its ticker, ABUS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Arbutus Biopharma trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Arbutus Biopharma position in USD and INR. Arbutus Biopharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Arbutus Biopharma from India
Trading and taxes when buying Arbutus Biopharma from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneArbutus Biopharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Arbutus Biopharma stock?
Yes. Arbutus Biopharma (ABUS) has been listed on NASDAQ since 2007, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Arbutus Biopharma share cost in rupees?
One Arbutus Biopharma share is $4.85 — about ₹465 at a USD/INR rate of 95.93 on 27 Sep 2026. Both the Arbutus Biopharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Arbutus Biopharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Arbutus Biopharma?
Yes. One Arbutus Biopharma share is $4.85, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Arbutus Biopharma.
How are gains on Arbutus Biopharma shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Arbutus Biopharma price. Paasa issues a capital-gains statement for your return.
Does Arbutus Biopharma pay a dividend?
No. Arbutus Biopharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Arbutus Biopharma from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Arbutus Biopharma shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Arbutus Biopharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Arbutus Biopharma holding, its cost and its closing value.
How do I sell Arbutus Biopharma and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.